Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons

Cell replacement therapy using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is a promising strategy for the treatment of neurologic diseases such as Parkinson's disease (PD). However, a limiting factor for effective cell transplantation is the low survival rate of graf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yoshikawa, Tatsuya, Samata, Bumpei, Ogura, Aya, Miyamoto, Susumu, Takahashi, Jun
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2013
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573719/
https://ncbi.nlm.nih.gov/pubmed/23423767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2013.00011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars